{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:51:33Z","timestamp":1785005493864,"version":"3.55.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001792","name":"James Cook University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multidrug-resistant (MDR)\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    poses a significant global health concern, particularly in hospital setting where it causes severe and hard-to-treat infections. In this study, 329 fungal-derived compounds were screened for their potential to inhibit MrkD1P, a key fimbrial adhesin protein (PDB ID: 3U4K) involved in host tissue adhesion. Molecular docking analysis identified ochratoxin A (\u2212\u20099.1\u00a0kcal\/mol), bromadiolone (\u2212\u20098.6\u00a0kcal\/mol), and permethrin (\u2212\u20098.2\u00a0kcal\/mol) as top-performing candidates, exhibiting strong binding affinities and stable molecular interactions, including hydrogen bonding and hydrophobic contacts. These findings were reinforced by 100-nanosecond molecular dynamics (MD) simulations, which showed sustained ligand\u2013protein stability, particularly for ochratoxin A. Free energy estimations using the MM\/PBSA method further suggested the thermodynamic favourability of these interactions. Pharmacokinetic profiling (ADMET) indicated favourable absorption and distribution properties for all three compounds, with low toxicity predictions, though some hepatotoxicity was noted. Principal component analysis (PCA) demonstrated that ochratoxin A and permethrin induced substantial alterations in protein dynamics, suggesting ligand-specific structural effects. Experimental validation confirmed the antibacterial activity of ochratoxin A against\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    , producing a 34\u2009\u00b1\u20090.67\u00a0mm inhibition zone at 100\u00a0\u00b5g\/disc, surpassing ciprofloxacin (33\u00a0mm) with a MIC of 18.33\u2009\u00b1\u20090.72\u00a0\u00b5g\/mL and MBC of 39.33\u2009\u00b1\u20091.36\u00a0\u00b5g\/mL (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Collectively, these in silico and in vitro results highlight fungal metabolites, particularly ochratoxin A, as promising therapeutic leads against MDR K.\n                    <jats:italic>pneumoniae<\/jats:italic>\n                    . However, further in vivo investigations are required to establish their safety and clinical potential.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10822-025-00661-w","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T09:08:19Z","timestamp":1758013699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fungal metabolite Ochratoxin A inhibits MrkD1P of multidrug-resistant Klebsiella pneumoniae: Integrated computational and in vitro validation"],"prefix":"10.1007","volume":"39","author":[{"given":"Md","family":"Roqunuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya Jahan","family":"Supti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbub Hasan","family":"Rifat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saiful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ummay Habiba","family":"Ananna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Saifullah","family":"Tusher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamal A.","family":"Al-Mutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5643-9202","authenticated-orcid":false,"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subir","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Eram","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"661_CR1","doi-asserted-by":"publisher","unstructured":"Fatima Z, Purkait D, Rehman S, Rai S, Hameed S (2023) Chapter 11 - Multidrug resistance: a threat to antibiotic era, in Hazards and Disasters Series, R. Sivanpillai and J. F. B. T.-B. and E. H. Shroder Risks, and Disasters (Second Edition), Eds., Boston: Elsevier, pp. 197\u2013220. https:\/\/doi.org\/10.1016\/B978-0-12-820509-9.00014-9","DOI":"10.1016\/B978-0-12-820509-9.00014-9"},{"issue":"10","key":"661_CR2","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","volume":"43","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A (2017) Antimicrobial resistance in the next 30 years, humankind, Bugs and drugs: a visionary approach. Intensive Care Med 43(10):1464\u20131475. https:\/\/doi.org\/10.1007\/s00134-017-4878-x","journal-title":"Intensive Care Med"},{"issue":"5","key":"661_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/j.1875-9114.2012.01035.x","volume":"32","author":"RP Rapp","year":"2012","unstructured":"Rapp RP, Urban C (2012) Klebsiella pneumoniae carbapenemases in enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacother J Hum Pharmacol Drug Ther 32(5):399\u2013407","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"661_CR4","doi-asserted-by":"publisher","first-page":"750662","DOI":"10.3389\/fmicb.2021.750662","volume":"12","author":"D Chang","year":"2021","unstructured":"Chang D, Sharma L, Dela Cruz CS, Zhang D (2021) Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol 12:750662","journal-title":"Front Microbiol"},{"issue":"1","key":"661_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12866-025-03798-8","volume":"25","author":"S Ara\u00fajo","year":"2025","unstructured":"Ara\u00fajo S, Silva V, Quintelas M, Martins \u00c2, Igrejas G, Poeta P (2025) From soil to surface water: exploring klebsiella\u2019s clonal lineages and antibiotic resistance odyssey in environmental health. BMC Microbiol 25(1):97","journal-title":"BMC Microbiol"},{"key":"661_CR6","doi-asserted-by":"publisher","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A (May 2017) Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 41(3):252\u2013275. https:\/\/doi.org\/10.1093\/femsre\/fux013","DOI":"10.1093\/femsre\/fux013"},{"key":"661_CR7","doi-asserted-by":"publisher","unstructured":"Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-Resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options, https:\/\/doi.org\/10.3390\/antibiotics12020234","DOI":"10.3390\/antibiotics12020234"},{"key":"661_CR8","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3389\/fmicb.2018.01422","volume":"9","author":"M-H Nicolas-Chanoine","year":"2018","unstructured":"Nicolas-Chanoine M-H, Mayer N, Guyot K, Dumont E, Pag\u00e8s J-M (2018) Interplay between membrane permeability and enzymatic barrier leads to antibiotic-dependent resistance in Klebsiella pneumoniae. Front Microbiol 9:1422","journal-title":"Front Microbiol"},{"key":"661_CR9","doi-asserted-by":"crossref","unstructured":"Li Y, Kumar S, Zhang L (2024) Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist, pp. 1107\u20131119","DOI":"10.2147\/IDR.S453025"},{"key":"661_CR10","doi-asserted-by":"publisher","unstructured":"Di Pilato V, Simona P, Vivi M, Gian Maria R, and M. M. and, D\u2019Andrea (2024) Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge, Expert Rev. Anti. Infect. Ther., vol. 22, no. 1\u20133, pp. 25\u201343, Mar. https:\/\/doi.org\/10.1080\/14787210.2024.2305854","DOI":"10.1080\/14787210.2024.2305854"},{"key":"661_CR11","doi-asserted-by":"publisher","unstructured":"Zhu J, Chen T, Ju Y, Dai J, Zhuge X (2024) Transmission dynamics and novel treatments of high risk Carbapenem-Resistant Klebsiella pneumoniae: the lens of one health, https:\/\/doi.org\/10.3390\/ph17091206","DOI":"10.3390\/ph17091206"},{"key":"661_CR12","doi-asserted-by":"publisher","first-page":"106026","DOI":"10.1016\/j.micpath.2023.106026","volume":"177","author":"Q Chen","year":"2023","unstructured":"Chen Q, Wang M, Han M, Xu L, Zhang H (2023) Molecular basis of Klebsiella pneumoniae colonization in host. Microb Pathog 177:106026. https:\/\/doi.org\/10.1016\/j.micpath.2023.106026","journal-title":"Microb Pathog"},{"issue":"3","key":"661_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J (2016) Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 80(3):629\u2013661","journal-title":"Microbiol Mol Biol Rev"},{"issue":"6","key":"661_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01863-18","volume":"9","author":"MJ Dorman","year":"2018","unstructured":"Dorman MJ, Feltwell T, Goulding DA, Parkhill J, Short FL (2018) The capsule regulatory network of Klebsiella pneumoniae defined by density-TraDISort. MBio 9(6):10\u20131128","journal-title":"MBio"},{"issue":"2","key":"661_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuy043","volume":"43","author":"JA Bengoechea","year":"2019","unstructured":"Bengoechea JA, Pessoa JS (2019) Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 43(2):123\u2013144","journal-title":"FEMS Microbiol Rev"},{"issue":"8","key":"661_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1365-2958.1990.tb00714.x","volume":"4","author":"A Tarkkanen","year":"1990","unstructured":"Tarkkanen A et al (1990) Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol 4(8):1353\u20131361","journal-title":"Mol Microbiol"},{"issue":"6","key":"661_CR17","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/IAI.66.6.2887-2894.1998","volume":"66","author":"TAS Sebghati","year":"1998","unstructured":"Sebghati TAS, Korhonen TK, Hornick DB, Clegg S (1998) Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun 66(6):2887\u20132894","journal-title":"Infect Immun"},{"issue":"4","key":"661_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/mmi.12023","volume":"86","author":"AT R\u00eago","year":"2012","unstructured":"R\u00eago AT, Johnson JG, Geibel S, Enguita FJ, Clegg S, Waksman G (2012) Crystal structure of the MrkD1P receptor binding domain of K Lebsiella pneumoniae and identification of the human collagen V binding interface. Mol Microbiol 86(4):882\u2013893","journal-title":"Mol Microbiol"},{"issue":"3","key":"661_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jbiosc.2023.06.011","volume":"136","author":"A Rohatgi","year":"2023","unstructured":"Rohatgi A, Gupta P (2023) Benzoic acid derivatives as potent antibiofilm agents against Klebsiella pneumoniae biofilm. J Biosci Bioeng 136(3):190\u2013197. https:\/\/doi.org\/10.1016\/j.jbiosc.2023.06.011","journal-title":"J Biosci Bioeng"},{"key":"661_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13225-011-0116-y","volume":"50","author":"AH Aly","year":"2011","unstructured":"Aly AH, Debbab A, Proksch P (2011) Fifty years of drug discovery from fungi. Fungal Divers 50:3\u201319","journal-title":"Fungal Divers"},{"issue":"1","key":"661_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12934-023-02118-x","volume":"22","author":"AH Hashem","year":"2023","unstructured":"Hashem AH et al (2023) Bioactive compounds and biomedical applications of endophytic fungi: a recent review. Microb Cell Fact 22(1):107","journal-title":"Microb Cell Fact"},{"issue":"5","key":"661_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1039\/C3NP70078J","volume":"31","author":"A Evidente","year":"2014","unstructured":"Evidente A et al (2014) Fungal metabolites with anticancer activity. Nat Prod Rep 31(5):617\u2013627","journal-title":"Nat Prod Rep"},{"key":"661_CR23","doi-asserted-by":"publisher","unstructured":"Conrado R, Gomes TC, Roque GS, De Souza AO (2022) Overview of bioactive fungal secondary metabolites: cytotoxic and antimicrobial compounds, https:\/\/doi.org\/10.3390\/antibiotics11111604","DOI":"10.3390\/antibiotics11111604"},{"key":"661_CR24","doi-asserted-by":"crossref","unstructured":"Konaklieva MI (2019) Addressing antimicrobial resistance through new medicinal and synthetic chemistry strategies, SLAS Discov. Adv. Life Sci. R&D, vol. 24, no. 4, pp. 419\u2013439","DOI":"10.1177\/2472555218812657"},{"key":"661_CR25","doi-asserted-by":"publisher","first-page":"111756","DOI":"10.1016\/j.biopha.2021.111756","volume":"140","author":"NGM Gomes","year":"2021","unstructured":"Gomes NGM, Madureira-Carvalho \u00c1, Dias-da-Silva D, Valent\u00e3o P, Andrade PB (2021) Biosynthetic versatility of marine-derived fungi on the delivery of novel antibacterial agents against priority pathogens. Biomed Pharmacother 140:111756. https:\/\/doi.org\/10.1016\/j.biopha.2021.111756","journal-title":"Biomed Pharmacother"},{"issue":"29","key":"661_CR26","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.2174\/0929867323666160210141912","volume":"23","author":"F Tamay-Cach","year":"2016","unstructured":"Tamay-Cach F et al (2016) In Silico studies most employed in the discovery of new antimicrobial agents. Curr Med Chem 23(29):3360\u20133373","journal-title":"Curr Med Chem"},{"key":"661_CR27","doi-asserted-by":"crossref","unstructured":"Brogi S, Ramalho TC, Kuca K, Medina-Franco JL, Valko M (2020) Editorial: in silico methods for drug design and discovery. Front Chem. ; 8: 612, 2020","DOI":"10.3389\/fchem.2020.00612"},{"key":"661_CR28","doi-asserted-by":"publisher","first-page":"563975","DOI":"10.3389\/fgene.2020.563975","volume":"11","author":"M Imchen","year":"2020","unstructured":"Imchen M et al (2020) Current trends in experimental and computational approaches to combat antimicrobial resistance. Front Genet 11:563975","journal-title":"Front Genet"},{"issue":"1","key":"661_CR29","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC et al (2023) Molecular Docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 13(1):13398","journal-title":"Sci Rep"},{"key":"661_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drudis.2010.10.003","volume":"15","author":"Q Li","year":"2010","unstructured":"Li Q, Cheng T, Wang Y, Bryant SH (2010) PubChem as a public resource for drug discovery. Drug Discov Today 15:23\u201324","journal-title":"Drug Discov Today"},{"key":"661_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3:1\u201314","journal-title":"J Cheminform"},{"issue":"W1","key":"661_CR32","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian W, Chen C, Lei X, Zhao J, Liang J (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46(W1):W363\u2013W367","journal-title":"Nucleic Acids Res"},{"key":"661_CR33","doi-asserted-by":"crossref","unstructured":"Land H, Humble MS (2018) YASARA: a tool to obtain structural guidance in biocatalytic investigations. Protein Eng Methods Protoc, pp. 43\u201367","DOI":"10.1007\/978-1-4939-7366-8_4"},{"key":"661_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1063\/1.4872239","volume":"140","author":"MF Harrach","year":"2014","unstructured":"Harrach MF, Drossel B (2014) Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys 140:17","journal-title":"J Chem Phys"},{"key":"661_CR35","doi-asserted-by":"crossref","unstructured":"Krieger E, Dunbrack RL, Hooft RWW, Krieger B (2012) Assignment of protonation States in proteins and ligands: combining pK a prediction with hydrogen bonding network optimization. Comput Drug Discov Des, pp. 405\u2013421","DOI":"10.1007\/978-1-61779-465-0_25"},{"issue":"19","key":"661_CR36","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103(19):8577\u20138593","journal-title":"J Chem Phys"},{"issue":"13","key":"661_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcc.23899","volume":"36","author":"E Krieger","year":"2015","unstructured":"Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36(13):996\u20131007","journal-title":"J Comput Chem"},{"issue":"12","key":"661_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33(12):889\u2013897","journal-title":"Acc Chem Res"},{"issue":"2","key":"661_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson\u2009\u2013\u2009Boltzmann surface area method. Mol Inf 31(2):114\u2013122","journal-title":"Mol Inf"},{"issue":"20","key":"661_CR40","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","volume":"30","author":"E Krieger","year":"2014","unstructured":"Krieger E, Vriend G (2014) YASARA View\u2014molecular graphics for all devices\u2014from smartphones to workstations. Bioinformatics 30(20):2981\u20132982","journal-title":"Bioinformatics"},{"issue":"4","key":"661_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/prot.340170408","volume":"17","author":"A Amadei","year":"1993","unstructured":"Amadei A, Linssen ABM, Berendsen HJC (1993) Essential dynamics of proteins. Proteins Struct Funct Bioinforma 17(4):412\u2013425","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"661_CR42","doi-asserted-by":"crossref","unstructured":"David CC, Jacobs DJ (2013) Principal component analysis: a method for determining the essential dynamics of proteins. in Protein dynamics: methods and protocols. Springer, pp 193\u2013226","DOI":"10.1007\/978-1-62703-658-0_11"},{"key":"661_CR43","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F et al (2011) Scikit-learn: machine learning in python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"03","key":"661_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: A 2D graphics environment. Comput Sci Eng 9(03):90\u201395","journal-title":"Comput Sci Eng"},{"issue":"9","key":"661_CR45","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072","journal-title":"J Med Chem"},{"issue":"1","key":"661_CR46","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717","journal-title":"Sci Rep"},{"key":"661_CR47","unstructured":"Wikler MA (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, Clsi, vol. 26"},{"issue":"2","key":"661_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock REW (2008) Agar and broth Dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3(2):163\u2013175","journal-title":"Nat Protoc"},{"issue":"6","key":"661_CR49","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jac\/dkf083","volume":"49","author":"JM Andrews","year":"2002","unstructured":"Andrews JM (2002) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 49(6):1049","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"661_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6(2):71\u201379. https:\/\/doi.org\/10.1016\/j.jpha.2015.11.005","journal-title":"J Pharm Anal"},{"issue":"10","key":"661_CR51","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1093\/jac\/dkae245","volume":"79","author":"TJ Harryvan","year":"2024","unstructured":"Harryvan TJ, Schaftenaar E, Franssens BT, Melles DC, Rentenaar RJ (2024) EUCAST Ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD phoenix\u2122 and VITEK\u00ae 2 automated susceptibility systems. J Antimicrob Chemother 79(10):2718\u20132719","journal-title":"J Antimicrob Chemother"},{"key":"661_CR52","doi-asserted-by":"crossref","unstructured":"Aditi Priyadarshini B, Mahalakshmi K, Kumar VN (2019) Mutant prevention concentration of ciprofloxacin against Klebsiella pneumoniae clinical isolates: an ideal prognosticator in treating multidrug-resistant strains, Int. J. Microbiol., vol. no. 1, p. 6850108, 2019","DOI":"10.1155\/2019\/6850108"},{"key":"661_CR53","doi-asserted-by":"publisher","first-page":"827451","DOI":"10.3389\/fmicb.2022.827451","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C et al (2022) Large-scale samples based rapid detection of Ciprofloxacin resistance in Klebsiella pneumoniae using machine learning methods. Front Microbiol 13:827451","journal-title":"Front Microbiol"},{"issue":"8","key":"661_CR54","first-page":"DL03","volume":"11","author":"YD Bakthavatchalam","year":"2017","unstructured":"Bakthavatchalam YD, Veeraraghavan B (2017) Challenges, issues and warnings from CLSI and EUCAST working group on polymyxin susceptibility testing. J Clin Diagn Res JCDR 11(8):DL03","journal-title":"J Clin Diagn Res JCDR"},{"issue":"1","key":"661_CR55","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41598-025-91505-y","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed M et al (2025) Insight into molecular and mutational scrutiny of epilepsy associated gene Gabrg2 leading to novel computer-aided drug designing. Sci Rep 15(1):6770. https:\/\/doi.org\/10.1038\/s41598-025-91505-y","journal-title":"Sci Rep"},{"key":"661_CR56","doi-asserted-by":"publisher","unstructured":"Rojmala JV, Thakkar AB, Joshi D, Waghela BN, Thakor P (Nov. 2024) Screening and identification of phytochemicals from <\u2009em\u2009>\u2009acorus calamus\u2009l. To overcome NDM-1 mediated resistance. Heliyon 10(22). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40211. in <\u2009em\u2009>\u2009Klebsiella pneumoniae\u2009using\u2009<\u2009em\u2009>\u2009in silico\u2009approach","DOI":"10.1016\/j.heliyon.2024.e40211"},{"issue":"24","key":"661_CR57","doi-asserted-by":"publisher","first-page":"13641","DOI":"10.1080\/07391102.2021.1993340","volume":"40","author":"V Chakkyarath","year":"2022","unstructured":"Chakkyarath V, Natarajan J (2022) Probing intermolecular interactions and binding stability of antimicrobial peptides with beta-lactamase of Klebsiella aerogenes by comparing FDA approved beta-lactam drugs: a Docking and molecular dynamics approach. J Biomol Struct Dyn 40(24):13641\u201313657","journal-title":"J Biomol Struct Dyn"},{"key":"661_CR58","doi-asserted-by":"publisher","unstructured":"Vaghasia VV, Sharma K, Mishra SK, Georrge JJ (2024) In: Kaneria M, Rakholiya K, and C. B. T.-N. and, Egbuna IST (eds) Chapter 21 - In Silico identification of natural product inhibitor for multidrug resistance proteins from selected gram-positive bacteria. Elsevier, pp 309\u2013317. doi: https:\/\/doi.org\/10.1016\/B978-0-443-15457-7.00015-0.","DOI":"10.1016\/B978-0-443-15457-7.00015-0"},{"issue":"1","key":"661_CR59","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.1038\/s41598-024-68403-w","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed M et al (2024) Optimizing the Resveratrol fragments for novel in Silico hepatocellular carcinoma de Novo drug design. Sci Rep 14(1):17336. https:\/\/doi.org\/10.1038\/s41598-024-68403-w","journal-title":"Sci Rep"},{"key":"661_CR60","doi-asserted-by":"publisher","unstructured":"Naveed M et al (2023) Chain-Engineering-Based de Novo drug design against MPXVgp169 virulent protein of Monkeypox virus: A molecular modification approach, https:\/\/doi.org\/10.3390\/bioengineering10010011","DOI":"10.3390\/bioengineering10010011"},{"issue":"8","key":"661_CR61","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1002\/mbo3.1054","volume":"9","author":"P Nikolic","year":"2020","unstructured":"Nikolic P, Mudgil P, Whitehall J (2020) The in vitro antibacterial effect of permethrin and formaldehyde on Staphylococcus aureus. Microbiologyopen 9(8):e1054","journal-title":"Microbiologyopen"},{"key":"661_CR62","doi-asserted-by":"publisher","unstructured":"Ostry V, Malir F, Ruprich J (2013) Producers and important dietary sources of Ochratoxin A and citrinin, https:\/\/doi.org\/10.3390\/toxins5091574","DOI":"10.3390\/toxins5091574"},{"key":"661_CR63","doi-asserted-by":"publisher","unstructured":"Klari\u0107 M\u0160, Ra\u0161i\u0107 D, Peraica M (2013) Deleterious effects of Mycotoxin combinations involving Ochratoxin A, https:\/\/doi.org\/10.3390\/toxins5111965","DOI":"10.3390\/toxins5111965"},{"key":"661_CR64","doi-asserted-by":"crossref","unstructured":"Ali-Vehmas T, Rizzo A, Westermarck T, Atroshi F (1998) Measurement of antibacterial activities of T\u20102 toxin, deoxynivalenol, ochratoxin A, aflatoxin B1 and fumonisin B1 using microtitration tray\u2010based turbidimetric techniques, J. Vet. Med. Ser. A, vol. 45, no. 1\u201010, pp. 453\u2013458","DOI":"10.1111\/j.1439-0442.1998.tb00848.x"},{"key":"661_CR65","doi-asserted-by":"publisher","unstructured":"Clark HA and S. M. and, Snedeker (2006) Ochratoxin a: Its Cancer Risk and Potential for Exposure, J. Toxicol. Environ. Heal. Part B, vol. 9, no. 3, pp. 265\u2013296, Jul. https:\/\/doi.org\/10.1080\/15287390500195570","DOI":"10.1080\/15287390500195570"},{"issue":"4","key":"661_CR66","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan K, Grauffel C, Lim C (2017) How molecular size impacts RMSD applications in molecular dynamics simulations. J Chem Theory Comput 13(4):1518\u20131524","journal-title":"J Chem Theory Comput"},{"key":"661_CR67","doi-asserted-by":"crossref","unstructured":"B. M. D. et al., Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from \u03b2-Lactamase Protein Engineering, MBio, vol. 8, no. 5, pp. (2017)","DOI":"10.1128\/mBio.00528-17"},{"issue":"5","key":"661_CR68","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s11030-023-10738-z","volume":"28","author":"J Dey","year":"2024","unstructured":"Dey J, Mahapatra SR, Raj TK, Misra N, Suar M (2024) Identification of potential flavonoid compounds as antibacterial therapeutics against Klebsiella pneumoniae infection using structure-based virtual screening and molecular dynamics simulation. Mol Divers 28(5):3111\u20133128. https:\/\/doi.org\/10.1007\/s11030-023-10738-z","journal-title":"Mol Divers"},{"key":"661_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","volume":"156","author":"M Arnittali","year":"2019","unstructured":"Arnittali M, Rissanou AN, Harmandaris V (2019) Structure of biomolecules through molecular dynamics simulations. Procedia Comput Sci 156:69\u201378. https:\/\/doi.org\/10.1016\/j.procs.2019.08.181","journal-title":"Procedia Comput Sci"},{"issue":"7","key":"661_CR70","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/biom11071040","volume":"11","author":"AL Leit\u00e3o","year":"2021","unstructured":"Leit\u00e3o AL, Enguita FJ (2021) Systematic structure-based search for ochratoxin-degrading enzymes in proteomes from filamentous fungi. Biomolecules 11(7):1040","journal-title":"Biomolecules"},{"key":"661_CR71","doi-asserted-by":"publisher","unstructured":"Elsayim R, Aloufi AS, Modafer Y, Eltayb WA, Alameen AA, Abdurahim SA (2023) Molecular dynamic analysis of Carbapenem-Resistant Klebsiella pneumonia\u2019s Porin proteins with beta lactam antibiotics and zinc oxide nanoparticles, https:\/\/doi.org\/10.3390\/molecules28062510","DOI":"10.3390\/molecules28062510"},{"key":"661_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-S1-S34","volume":"12","author":"I Chikalov","year":"2011","unstructured":"Chikalov I, Yao P, Moshkov M, Latombe J-C (2011) Learning probabilistic models of hydrogen bond stability from molecular dynamics simulation trajectories. BMC Bioinformatics 12:1\u20136","journal-title":"BMC Bioinformatics"},{"key":"661_CR73","doi-asserted-by":"crossref","unstructured":"Fu Y, Zhao J, Chen Z (2018) Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation: a case of oligopeptide binding protein, Comput. Math. Methods Med., vol. no. 1, p. 3502514, 2018","DOI":"10.1155\/2018\/3502514"},{"key":"661_CR74","doi-asserted-by":"crossref","unstructured":"Shukla R, Tripathi T (2020) Molecular dynamics simulation of protein and protein\u2013ligand complexes. Comput Drug Des, pp. 133\u2013161","DOI":"10.1007\/978-981-15-6815-2_7"},{"issue":"3","key":"661_CR75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12539-018-0299-y","volume":"11","author":"S Ahmad","year":"2019","unstructured":"Ahmad S, Navid A, Akhtar AS, Azam SS, Wadood A, P\u00e9rez-S\u00e1nchez H (2019) Subtractive genomics, molecular Docking and molecular dynamics simulation revealed LpxC as a potential drug target against multi-drug resistant Klebsiella pneumoniae. Interdiscip Sci Comput Life Sci 11(3):508\u2013526","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"2","key":"661_CR76","doi-asserted-by":"publisher","first-page":"e0317622","DOI":"10.1371\/journal.pone.0317622","volume":"20","author":"A Kumar","year":"2025","unstructured":"Kumar A, Anjum F, Hassan MI, Shamsi A, Singh RP (2025) Identification and prioritization of novel therapeutic candidates against glutamate racemase from Klebsiella pneumoniae. PLoS ONE 20(2):e0317622","journal-title":"PLoS ONE"},{"issue":"5","key":"661_CR77","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LLG Ferreira","year":"2019","unstructured":"Ferreira LLG, Andricopulo AD (2019) ADMET modeling approaches in drug discovery. Drug Discov Today 24(5):1157\u20131165","journal-title":"Drug Discov Today"},{"issue":"3","key":"661_CR78","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Van De Waterbeemd","year":"2003","unstructured":"Van De Waterbeemd H, Gifford E (2003) ADMET in Silico modelling: towards prediction paradise? Nat Rev Drug Discov 2(3):192\u2013204","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"661_CR79","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4155\/fmc-2019-0206","volume":"12","author":"S Fatima","year":"2020","unstructured":"Fatima S, Gupta P, Sharma S, Sharma A, Agarwal SM (2020) ADMET profiling of geographically diverse phytochemical using chemoinformatic tools. Future Med Chem 12(1):69\u201387","journal-title":"Future Med Chem"},{"key":"661_CR80","doi-asserted-by":"crossref","unstructured":"Maliehe TS, Tsilo PH, Shandu JS (2020) Computational evaluation of ADMET properties and bioactive score of compounds from encephalartos ferox. Pharmacogn J, 12, 6","DOI":"10.5530\/pj.2020.12.187"},{"issue":"8","key":"661_CR81","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1021\/acs.jmedchem.7b00935","volume":"61","author":"C Kramer","year":"2017","unstructured":"Kramer C et al (2017) Learning medicinal chemistry absorption, distribution, metabolism, excretion, and toxicity (ADMET) rules from cross-company matched molecular pairs analysis (MMPA) miniperspective. J Med Chem 61(8):3277\u20133292","journal-title":"J Med Chem"},{"issue":"1","key":"661_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M (2004) The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16(1):1\u201313","journal-title":"Neurobiol Dis"},{"key":"661_CR83","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ (2013) Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437\u2013449","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"661_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ (2010) Structure and function of the blood\u2013brain barrier. Neurobiol Dis 37(1):13\u201325","journal-title":"Neurobiol Dis"},{"issue":"9","key":"661_CR85","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1089\/cmb.2019.0323","volume":"27","author":"X Chen","year":"2020","unstructured":"Chen X, Li H, Tian L, Li Q, Luo J, Zhang Y (2020) Analysis of the physicochemical properties of acaricides based on lipinski\u2019s rule of five. J Comput Biol 27(9):1397\u20131406","journal-title":"J Comput Biol"},{"key":"661_CR86","doi-asserted-by":"crossref","unstructured":"Pradeepkiran JA, Sainath SB, Shrikanya KVL (2021) In Silico validation and ADMET analysis for the best lead molecules. in Brucella melitensis. Elsevier, pp 133\u2013176","DOI":"10.1016\/B978-0-323-85681-2.00008-2"},{"issue":"4","key":"661_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337\u2013341","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"661_CR88","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/C8MD00472B","volume":"10","author":"L Guan","year":"2019","unstructured":"Guan L et al (2019) ADMET-score\u2013a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm 10(1):148\u2013157","journal-title":"Medchemcomm"},{"issue":"2","key":"661_CR89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/jof11020093","volume":"11","author":"V Alves","year":"2025","unstructured":"Alves V, Zamith-Miranda D, Frases S, Nosanchuk JD (2025) Fungal metabolomics: A comprehensive approach to Understanding pathogenesis in humans and identifying potential therapeutics. J Fungi 11(2):93","journal-title":"J Fungi"},{"issue":"1","key":"661_CR90","doi-asserted-by":"publisher","first-page":"e56033","DOI":"10.15252\/embr.202256033","volume":"24","author":"S Walesch","year":"2023","unstructured":"Walesch S et al (2023) Fighting antibiotic resistance\u2014strategies and (pre) clinical developments to find new antibacterials. EMBO Rep 24(1):e56033","journal-title":"EMBO Rep"},{"issue":"4","key":"661_CR91","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/toxins8040111","volume":"8","author":"T K\u0151szegi","year":"2016","unstructured":"K\u0151szegi T, Po\u00f3r M (2016) Ochratoxin A: molecular interactions, mechanisms of toxicity and prevention at the molecular level. Toxins (Basel) 8(4):111","journal-title":"Toxins (Basel)"},{"issue":"7","key":"661_CR92","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1139\/m75-143","volume":"21","author":"K Heller","year":"1975","unstructured":"Heller K, Schulz C, L\u00f6ser R, R\u00f6schenthaler R (1975) The Inhibition of bacterial growth by Ochratoxin A. Can J Microbiol 21(7):972\u2013979","journal-title":"Can J Microbiol"},{"issue":"3","key":"661_CR93","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1574-6968.1978.tb02852.x","volume":"4","author":"A Wegner","year":"1978","unstructured":"Wegner A, R\u00f6schenthaler R (1978) Inhibition of Bacillus subtilis sporulation by Ochratoxin A. FEMS Microbiol Lett 4(3):147\u2013150","journal-title":"FEMS Microbiol Lett"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00661-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00661-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:02:45Z","timestamp":1762452165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00661-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00661-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}